Vithas Hospitales on X: "La URHA de Vithas #Granada dirigida por el doctor Salomón Menjón Beltrán brinda asistencia personalizada en técnicas de inseminación artificial y #fecundación in vitro con la seguridad de
![Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY | Breast Cancer Research and Treatment Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY | Breast Cancer Research and Treatment](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10549-023-07165-x/MediaObjects/10549_2023_7165_Fig1_HTML.png)
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY | Breast Cancer Research and Treatment
![El Dr. Daniel Lubián, responsable de Ginecología del hospital Viamed Bahía de Cádiz lleva a cabo un estudio en pacientes con cáncer de mama - Viamed - Espacio de Salud El Dr. Daniel Lubián, responsable de Ginecología del hospital Viamed Bahía de Cádiz lleva a cabo un estudio en pacientes con cáncer de mama - Viamed - Espacio de Salud](https://espaciosalud.viamedsalud.com/wp-content/uploads/2021/04/lubian-scaled-e1619106539458.jpg)
El Dr. Daniel Lubián, responsable de Ginecología del hospital Viamed Bahía de Cádiz lleva a cabo un estudio en pacientes con cáncer de mama - Viamed - Espacio de Salud
![Ernesto GONZÁLEZ-MESA | Professor Malaga University | PhD, MD | Obstetrics and Gynecology | Research profile Ernesto GONZÁLEZ-MESA | Professor Malaga University | PhD, MD | Obstetrics and Gynecology | Research profile](https://i1.rgstatic.net/ii/profile.image/272781866696720-1442047673407_Q512/Ernesto-Gonzalez-Mesa.jpg)
Ernesto GONZÁLEZ-MESA | Professor Malaga University | PhD, MD | Obstetrics and Gynecology | Research profile
![Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) - ScienceDirect Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419311615-gr1.jpg)
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) - ScienceDirect
![Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY | Breast Cancer Research and Treatment Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY | Breast Cancer Research and Treatment](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10549-023-07165-x/MediaObjects/10549_2023_7165_Fig2_HTML.png)